178 related articles for article (PubMed ID: 22305241)
21. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
Italiano A; Hostein I; Soubeyran I; Fabas T; Benchimol D; Evrard S; Gugenheim J; Becouarn Y; Brunet R; Fonck M; François E; Saint-Paul MC; Pedeutour F
Ann Surg Oncol; 2010 May; 17(5):1429-34. PubMed ID: 20049644
[TBL] [Abstract][Full Text] [Related]
22. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
23. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
24. The role of p53 mutation in the carcinomas arising from endometriosis.
Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas.
Kotoula V; Sozopoulos E; Litsiou H; Fanourakis G; Koletsa T; Voutsinas G; Tseleni-Balafouta S; Mitsiades CS; Wellmann A; Mitsiades N
Endocr Relat Cancer; 2009 Jun; 16(2):565-72. PubMed ID: 19190079
[TBL] [Abstract][Full Text] [Related]
26. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
Amemiya S; Sekizawa A; Otsuka J; Tachikawa T; Saito H; Okai T
Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
[TBL] [Abstract][Full Text] [Related]
27. Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
Linder A; Westbom-Fremer S; Mateoiu C; Olsson Widjaja A; Österlund T; Veerla S; Ståhlberg A; Ulfenborg B; Hedenfalk I; Sundfeldt K
Hum Reprod; 2024 May; 39(5):1141-1154. PubMed ID: 38459814
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.
Kurman RJ; Shih IeM
Int J Gynecol Pathol; 2008 Apr; 27(2):151-60. PubMed ID: 18317228
[TBL] [Abstract][Full Text] [Related]
29. Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: A possible link to endometrioid adenocarcinoma.
Körner M; Burckhardt E; Mazzucchelli L
Mod Pathol; 2006 Dec; 19(12):1615-23. PubMed ID: 16980942
[TBL] [Abstract][Full Text] [Related]
30. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
Gemignani ML; Schlaerth AC; Bogomolniy F; Barakat RR; Lin O; Soslow R; Venkatraman E; Boyd J
Gynecol Oncol; 2003 Aug; 90(2):378-81. PubMed ID: 12893203
[TBL] [Abstract][Full Text] [Related]
31. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of endometriosis in malignant epithelial ovary tumours.
Oral E; Ilvan S; Tustas E; Korbeyli B; Bese T; Demirkiran F; Arvas M; Kosebay D
Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):97-101. PubMed ID: 12818453
[TBL] [Abstract][Full Text] [Related]
33. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
Mhawech P; Kinkel K; Vlastos G; Pelte MF
Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis.
Vestergaard AL; Thorup K; Knudsen UB; Munk T; Rosbach H; Poulsen JB; Guldberg P; Martensen PM
Mol Hum Reprod; 2011 Dec; 17(12):758-61. PubMed ID: 21724579
[TBL] [Abstract][Full Text] [Related]
35. [Molecular pathology of epithelial ovarian neoplasias: from the phenotype-genotype correlation to new targets in diagnostics and therapy].
Staebler A; Diebold J
Pathologe; 2007 May; 28(3):180-6. PubMed ID: 17431628
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetic defects in endometriosis.
Thomas EJ; Campbell IG
Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
[TBL] [Abstract][Full Text] [Related]
37. Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis.
Ayhan A; Kurman RJ; Yemelyanova A; Vang R; Logani S; Seidman JD; Shih IeM
Am J Surg Pathol; 2009 Aug; 33(8):1220-4. PubMed ID: 19461510
[TBL] [Abstract][Full Text] [Related]
38. Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.
Anglesio MS; Arnold JM; George J; Tinker AV; Tothill R; Waddell N; Simms L; Locandro B; Fereday S; Traficante N; Russell P; Sharma R; Birrer MJ; ; deFazio A; Chenevix-Trench G; Bowtell DD
Mol Cancer Res; 2008 Nov; 6(11):1678-90. PubMed ID: 19010816
[TBL] [Abstract][Full Text] [Related]
39. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.
Kurman RJ; Visvanathan K; Roden R; Wu TC; Shih IeM
Am J Obstet Gynecol; 2008 Apr; 198(4):351-6. PubMed ID: 18395030
[TBL] [Abstract][Full Text] [Related]
40. Low-grade serous carcinoma of the ovary displaying a macropapillary pattern of invasion.
Yemelyanova A; Mao TL; Nakayama N; Shih IeM; Kurman RJ
Am J Surg Pathol; 2008 Dec; 32(12):1800-6. PubMed ID: 18779727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
